EPISODE · Feb 1, 2025 · 27 MIN
Christine Caldwell, Part Two: End of Life Psychedelic Care
from Conscious Physician: Medicine & Psychedelics · host Lida Fatemi
In part two of our conversation with the wonderful Christine Caldwell we dive deep into the role of psychedelics, particularly psilocybin, in easing the final stage of life and fostering profound healing experiences. In the second half of the conversation, they explore: Micro and macro dosing psilocybin for terminal care Mystical experiences as a healing ally Fascinating reports of patients dialoguing with their illnesses Goosebump-worthy stories of transformation from Caldwell’s work Rethinking the double-blind experiment in psychedelic research The liberating permission of individuality in quality-of-life discussions This conversation is rich with insight and heart, offering new perspectives on how psychedelics may serve as a compassionate bridge in life's most tender moments. Learn more about End of Life Psychedelic Care
What this episode covers
In part two of our conversation with the wonderful Christine Caldwell we dive deep into the role of psychedelics, particularly psilocybin, in easing the final stage of life and fostering profound healing experiences. In the second half of the conversation, they explore: Micro and macro dosing psilocybin for terminal care Mystical experiences as a healing ally Fascinating reports of patients dialoguing with their illnesses Goosebump-worthy stories of transformation from Caldwell’s work Rethinking the double-blind experiment in psychedelic research The liberating permission of individuality in quality-of-life discussions This conversation is rich with insight and heart, offering new perspectives on how psychedelics may serve as a compassionate bridge in life's most tender moments. Learn more about End of Life Psychedelic Care
NOW PLAYING
Christine Caldwell, Part Two: End of Life Psychedelic Care
No transcript for this episode yet
Similar Episodes
Apr 20, 2026 ·57m
Apr 13, 2026 ·59m
Apr 6, 2026 ·67m
Apr 3, 2026 ·3m
Apr 1, 2026 ·62m
Mar 26, 2026 ·4m